Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
| ▸ | REN | P00797 | 1/20 | 0.41 |
| ▸ | KLK7 | P49862 | 2/20 | 0.40 |
| ▸ | CTSC | P53634 | 2/20 | 0.39 |
| ▸ | EED | O75530 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30423293 | 0.95 | MEN1 (0.43) | MMEMEN1KMT2ADPP7REN | |
| SCHEMBL31721020 | 0.95 | MEN1 (0.43) | MMEMEN1KMT2ADPP7REN | |
| SCHEMBL29762027 | 0.94 | MEN1 (0.45) | MEN1KMT2ADPP7RENCTSC | |
| SCHEMBL29519785 | 0.90 | MEN1 (0.45) | MMEMEN1KMT2ADPP7KLK7 | |
| SCHEMBL29590887 | 0.90 | TASP1 (0.44) | MMEMEN1KMT2ADPP7REN | |
| SCHEMBL6373762 | 0.88 | MEN1 (0.49) | MEN1KMT2ADPP7RENCTSC | |
| SCHEMBL22295667 | 0.88 | MEN1 (0.49) | MEN1KMT2ADPP7RENCTSC | |
| SCHEMBL3041931 | 0.88 | MEN1 (0.49) | MEN1KMT2ADPP7RENCTSC | |
| SCHEMBL29876413 | 0.88 | MEN1 (0.49) | MEN1KMT2ADPP7RENCTSC | |
| SCHEMBL29578356 | 0.88 | MEN1 (0.49) | MEN1KMT2ADPP7RENCTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181696-A1 | POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING NEUROBLASTOMA AND USE THEREOF | Zhuhai Tengbai Pharmaceutical Co., Ltd. (CN) | 2023-06-15 | — | — | US | disclosed |